SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-037215
Filing Date
2021-09-22
Accepted
2021-09-22 21:57:03
Documents
1
Period of Report
2021-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 11835
  Complete submission text file 0000899243-21-037215.txt   13691
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Issuer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2121 AVENUE OF THE STARS SUITE 2300 LOS ANGELES CA 90067
Business Address 2121 AVENUE OF THE STARS SUITE 2300 LOS ANGELES CA 90067 (310) 209-7280
Eagle Equity Partners III, LLC (Reporting) CIK: 0001840996 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40097 | Film No.: 211270871